ASX:CYC

Cyclopharm Limited (CYC.AX) Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range

A$1.36

MA: A$1.36▼

A$1.36

52-Week Range N/A

Volume10,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield0.40%

BetaN/A

Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables, which are used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments in hospitals. The company has research collaboration agreement with McMasters University and others to understand the short-term and long-term effects of COVID-19 on lung ventilation and perfusion injury. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Overall MarketRank^™

0.79 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cyclopharm Limited (CYC.AX).

2.3 Community Rank

Outperform Votes
Cyclopharm Limited (CYC.AX) has received 10 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cyclopharm Limited (CYC.AX) has received 12 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cyclopharm Limited (CYC.AX) has received 54.55% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cyclopharm Limited (CYC.AX) and other stocks. Vote “Outperform” if you believe CYC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cyclopharm Limited (CYC.AX) has a dividend yield of 0.40%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cyclopharm Limited (CYC.AX) does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cyclopharm Limited (CYC.AX) insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$2,260.00 in company stock and sold A$0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange ASX

Industry Medical Devices

Sub-IndustryN/A

SectorMedical

Current SymbolASX:CYC

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.cyclopharm.com.au

Phone61 2 9541 0411

EmployeesN/A

Debt

Debt-to-Equity Ratio28.46

Current Ratio2.76

Quick Ratio2.01

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$16.28 million

Price / Sales0.00

Cash FlowN/A

Price / Cash Flow8.40

Book ValueA$0.21 per share

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Receive CYC News and Ratings via Email

Sign-up to receive the latest news and ratings for CYC and its competitors with MarketBeat's FREE daily newsletter.

Cyclopharm Limited (CYC.AX) (ASX:CYC) Frequently Asked Questions

What stocks does MarketBeat like better than Cyclopharm Limited (CYC.AX)?

Wall Street analysts have given Cyclopharm Limited (CYC.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cyclopharm Limited (CYC.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How often does Cyclopharm Limited (CYC.AX) pay dividends? What is the dividend yield for Cyclopharm Limited (CYC.AX)?

Cyclopharm Limited (CYC.AX) announced a Interim dividend on Wednesday, August 26th. Shareholders of record on Monday, September 14th will be paid a dividend of 0.005 per share on Monday, September 14th. This represents a yield of 0.37%. The ex-dividend date is Friday, September 4th.
View Cyclopharm Limited (CYC.AX)'s dividend history.

Is Cyclopharm Limited (CYC.AX) a good dividend stock?

Cyclopharm Limited (CYC.AX) pays an annual dividend of A$0.01 per share and currently has a dividend yield of 0.40%.
View Cyclopharm Limited (CYC.AX)'s dividend history.

Who are some of Cyclopharm Limited (CYC.AX)'s key competitors?

Some companies that are related to Cyclopharm Limited (CYC.AX) include Adherium Limited (ADR.AX) (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics Limited (AMT.AX) (AMT), Analytica Limited (ALT.AX) (ALT), AnteoTech Limited (ADO.AX) (ADO), Atomo Diagnostics Limited (AT1.AX) (AT1), AVITA Medical, Inc. (AVH.AX) (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), Cochlear (CHEOY), Cochlear (CHEOF), Cochlear Limited (COH.AX) (COH), EMvision Medical Devices Limited (EMV.AX) (EMV), Fisher & Paykel Healthcare Co. Limited (FPH.AX) (FPH) and GI Dynamics, Inc. (GID.AX) (GID).
View all of CYC's competitors.

Who are Cyclopharm Limited (CYC.AX)'s key executives?

Cyclopharm Limited (CYC.AX)'s management team includes the following people:

Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM, CEO, MD, Company Sec. & Director (Age 55, Pay $433.74k)
Mr. Mathew Farag, Chief Operating Officer
Mr. Graham N. Phillips, Fin. Mang.
Dr. Mark Doverty, Global Head of Regulatory Compliance & Clinical Research
Ms. Sally-Ann Cornelius, Head of Sales
Ms. Niamh McAree, Head of Quality and Regulatory
Mr. Chris Quinn, Head of Service
Ms. Sui Ling Cheah, Financial Controller (Age 50)
Mr. Lynn McLauchlin, Gen. Mang. of Canada
Mr. Bjorn Altmann, Gen. Mang. of Europe

What is Cyclopharm Limited (CYC.AX)'s stock symbol?

Cyclopharm Limited (CYC.AX) trades on the ASX under the ticker symbol "CYC."

How big of a company is Cyclopharm Limited (CYC.AX)?

Cyclopharm Limited (CYC.AX) has a market capitalization of $0.00 and generates $16.28 million in revenue each year. Cyclopharm Limited (CYC.AX) employs 37 workers across the globe.

What is Cyclopharm Limited (CYC.AX)'s official website?

The official website for Cyclopharm Limited (CYC.AX) is www.cyclopharm.com.au.

How can I contact Cyclopharm Limited (CYC.AX)?

The company can be reached via phone at 61 2 9541 0411.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Cyclopharm Limited (CYC.AX) Stock Forecast, Price & News

Adding

Adding

Adding Cyclopharm Limited (CYC.AX)

MarketRank™

Overall MarketRank™